J&J’s JNJ stock closed at $145.05 on Friday, quite close to its 52-week low of $142.75. In the past three months, J&J’s stock has lost more than 10%.Slowing sales of J&J’s MedTech segment, the upcoming patent expiration of its blockbuster drug, Stelara and talc-related legal issues are some of J&J’s...